PriceTargets.com logo

Genius Sports - GENI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $12.63
  • Forecasted Upside: 17.09%
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 14 Buy Ratings
  • 1 Strong Buy Ratings
$10.79 As of 07/16/2025 04:59 PM ET
▲ +0.559 (5.46%)

This chart shows the closing price for GENI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Genius Sports Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GENI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GENI

Analyst Price Target is $12.63
▲ +17.09% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Genius Sports in the last 3 months. The average price target is $12.63, with a high forecast of $15.00 and a low forecast of $11.00. The average price target represents a 17.09% upside from the last price of $10.79.

This chart shows the closing price for GENI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 16 investment analysts is to buy stock in Genius Sports. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/23/2024
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2024
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2024
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2025
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/17/2025
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/16/2025
  • 1 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/16/2025

Latest Recommendations

  • 1 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/9/2025Arete ResearchUpgradeStrong-Buy
7/9/2025AreteInitiated CoverageBuy$15.00
7/1/2025Truist FinancialInitiated CoverageBuy$14.00
6/30/2025CitigroupReiterated RatingOutperform ➝ Outperform
6/30/2025JMP SecuritiesSet TargetMarket Outperform ➝ Market Outperform$12.00 ➝ $13.00
6/12/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$13.00
5/7/2025B. RileyReiterated RatingBuy ➝ Buy
5/6/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$13.00 ➝ $13.00
4/22/2025BTIG ResearchBoost TargetBuy ➝ Buy$11.00 ➝ $12.00
4/21/2025Deutsche Bank AktiengesellschaftInitiated CoverageBuy$12.00
4/17/2025BenchmarkReiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/18/2025GuggenheimInitiated CoverageBuy$12.00
3/18/2025B. RileyInitiated CoverageBuy
3/5/2025Needham & Company LLCSet Target$13.00
3/5/2025Lake Street CapitalBoost TargetBuy ➝ Buy$10.50 ➝ $11.00
3/5/2025The Goldman Sachs GroupBoost TargetBuy ➝ Buy$11.00 ➝ $12.50
3/5/2025BenchmarkBoost TargetBuy ➝ Buy$11.00 ➝ $12.00
3/4/2025Craig HallumSet Target$15.00
3/4/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
1/27/2025JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$11.00 ➝ $11.00
1/17/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
1/16/2025JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$11.00 ➝ $11.00
1/6/2025Citizens JmpDowngradeStrong-Buy ➝ Hold
1/6/2025JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Perform$11.00 ➝ $11.00
11/27/2024CitigroupBoost TargetBuy ➝ Buy$10.00 ➝ $12.00
11/14/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$8.50 ➝ $11.50
11/13/2024B. RileyBoost TargetBuy ➝ Buy$10.00 ➝ $12.00
11/13/2024BenchmarkBoost TargetBuy ➝ Buy$10.00 ➝ $11.00
11/13/2024MacquarieBoost TargetOutperform ➝ Outperform$10.00 ➝ $12.00
11/13/2024OppenheimerBoost TargetOutperform ➝ Outperform$10.00 ➝ $12.00
11/12/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
10/11/2024BenchmarkReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
9/26/2024BenchmarkReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
9/10/2024BenchmarkReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
8/8/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$7.50 ➝ $8.50
8/7/2024B. RileyBoost TargetBuy ➝ Buy$9.00 ➝ $10.00
8/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
7/18/2024MacquarieLower TargetOutperform ➝ Outperform$10.00 ➝ $9.00
7/11/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
6/13/2024CitigroupInitiated CoverageBuy ➝ Buy$9.00
5/9/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$8.00 ➝ $9.00
5/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$9.00
4/16/2024The Goldman Sachs GroupInitiated CoverageBuy$7.50
4/5/2024B. RileyInitiated CoverageBuy$9.00
4/4/2024OppenheimerReiterated RatingOutperform ➝ Outperform$10.00
3/7/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$8.00
3/7/2024BenchmarkReiterated RatingBuy ➝ Buy$10.00
3/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$9.00
2/26/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$8.00
1/19/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$9.00
12/21/2023MacquarieInitiated CoverageOutperform$11.00
11/14/2023Craig HallumLower TargetBuy ➝ Buy$15.00 ➝ $12.00
11/14/2023BenchmarkReiterated RatingBuy ➝ Buy$10.00
11/14/2023Needham & Company LLCLower TargetBuy ➝ Buy$10.00 ➝ $9.00
10/12/2023Cantor FitzgeraldInitiated CoverageOverweight$8.00
9/27/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$9.00
9/5/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$9.00
8/8/2023Lake Street CapitalBoost Target$7.00 ➝ $8.50
8/8/2023OppenheimerBoost TargetOutperform ➝ Outperform$7.00 ➝ $10.00
8/8/2023B. RileyBoost Target$9.00 ➝ $10.00
8/8/2023BenchmarkBoost TargetBuy ➝ Buy$9.00 ➝ $10.00
8/8/2023Needham & Company LLCBoost TargetBuy ➝ Buy$8.00 ➝ $10.00
7/19/2023CitigroupBoost Target$7.00 ➝ $9.00
7/13/2023JMP SecuritiesBoost Target$8.00 ➝ $9.00
7/11/2023BTIG ResearchBoost Target$6.00 ➝ $9.00
6/5/2023JMP SecuritiesBoost Target$7.00 ➝ $8.00
5/25/2023Lake Street CapitalInitiated CoverageBuy$7.00
4/13/2023JMP SecuritiesReiterated RatingMarket Outperform$7.00
3/20/2023BTIG ResearchInitiated CoverageBuy$6.00
3/20/2023JMP SecuritiesInitiated CoverageOutperform$7.00
3/13/2023Needham & Company LLCReiterated RatingBuy$7.00
3/13/2023Credit Suisse GroupLower TargetOutperform$10.00 ➝ $8.00
8/17/2022Credit Suisse GroupLower TargetOutperform$11.00 ➝ $10.00
8/17/2022B. RileyBoost Target$5.25 ➝ $8.00
8/17/2022Needham & Company LLCBoost TargetBuy$6.00 ➝ $7.00
7/7/2022CitigroupLower TargetBuy$8.00 ➝ $6.00
6/28/2022B. RileyLower TargetBuy$9.00 ➝ $5.50
6/9/2022CitigroupLower TargetBuy$12.00 ➝ $8.00
5/25/2022B. RileyLower Target$13.00 ➝ $9.00
3/17/2022UBS GroupLower TargetNeutral$9.00 ➝ $5.00
3/14/2022Craig HallumLower Target$22.00 ➝ $17.00
3/14/2022B. RileyLower Target$17.00 ➝ $13.00
3/14/2022Credit Suisse GroupLower TargetOutperform$15.00 ➝ $14.00
3/14/2022Needham & Company LLCLower TargetBuy$13.00 ➝ $9.00
1/28/2022B. RileyLower Target$23.00 ➝ $17.00
1/19/2022Credit Suisse GroupInitiated CoverageOutperform$15.00
1/4/2022Craig HallumLower Target$27.00 ➝ $22.00
12/1/2021CitigroupUpgradeBuy$22.00 ➝ $13.00
11/24/2021B. RileyLower TargetBuy$32.00 ➝ $23.00
11/24/2021Craig HallumBoost TargetBuy$27.00 ➝ $32.00
11/24/2021BenchmarkLower TargetIn-Line ➝ Buy$33.00 ➝ $20.00
11/24/2021Needham & Company LLCLower TargetBuy$29.00 ➝ $22.00
10/11/2021UBS GroupInitiated CoverageNeutral$18.00
10/11/2021CitigroupInitiated CoverageBuy$22.00
9/23/2021Needham & Company LLCReiterated RatingBuy$29.00
9/10/2021B. RileyInitiated CoverageBuy
9/8/2021Needham & Company LLCReiterated RatingBuy$28.00
7/28/2021The Goldman Sachs GroupLower TargetBuy$31.00 ➝ $29.00
6/14/2021OppenheimerReiterated RatingBuy$32.00
6/7/2021Needham & Company LLCInitiated CoverageBuy$28.00
6/2/2021The Goldman Sachs GroupInitiated CoverageBuy$31.00
5/21/2021BenchmarkBoost TargetBuy$30.00 ➝ $33.00
5/21/2021OppenheimerBoost TargetOutperform$25.00 ➝ $32.00
5/3/2021OppenheimerInitiated CoverageOutperform$25.00
4/26/2021OppenheimerInitiated CoverageOutperform$25.00
(Data available from 7/17/2020 forward)

News Sentiment Rating

0.62 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/19/2024
  • 10 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
1/18/2025
  • 6 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/17/2025
  • 16 very positive mentions
  • 20 positive mentions
  • 8 negative mentions
  • 2 very negative mentions
Mentions as of
3/19/2025
  • 14 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/18/2025
  • 36 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
5/18/2025
  • 18 very positive mentions
  • 21 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
6/17/2025
  • 11 very positive mentions
  • 22 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
7/17/2025

Current Sentiment

  • 11 very positive mentions
  • 22 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Genius Sports logo
Genius Sports Limited engages in the development and sale of technology-led products and services to the sports, sports betting, and sports media industries. It offers technology infrastructure for the collection, integration, and distribution of live data of sports leagues; streaming solutions comprising technology, automatic production, and distribution for sports to commercialize video footage of their games; and end-to-end integrity services to sports leagues, such as full-time active monitoring technology, which uses mathematical algorithms to identify and flag suspicious betting activity in global betting markets, as well as a full suite of online and offline educational and consultancy services. The company also provides live sports data collection; pre-game and in-game odds feeds; risk management services, including customer profiling, monitoring of incoming bets, automated acceptance and rejection of bets, and limit setting; live streaming services; creation, delivery, and optimization of digital marketing campaigns, such as data-driven personalized ad creative; and fan engagement widgets for digital publishers that offer live game statistics and betting-related content. The company was founded in 2001 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $10.79
Low: $10.31
High: $10.99

50 Day Range

MA: $9.99
Low: $9.35
High: $10.86

52 Week Range

Now: $10.79
Low: $5.60
High: $11.40

Volume

6,432,333 shs

Average Volume

3,374,565 shs

Market Capitalization

$2.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Frequently Asked Questions

What sell-side analysts currently cover shares of Genius Sports?

The following Wall Street research analysts have issued research reports on Genius Sports in the last year: Arete, Arete Research, B. Riley, Benchmark Co., BTIG Research, Citigroup Inc., Citizens Jmp, Craig Hallum, Deutsche Bank Aktiengesellschaft, Guggenheim, JMP Securities, Lake Street Capital, Macquarie, Needham & Company LLC, Oppenheimer Holdings, Inc., The Goldman Sachs Group, Inc., and Truist Financial Corporation.
View the latest analyst ratings for GENI.

What is the current price target for Genius Sports?

0 Wall Street analysts have set twelve-month price targets for Genius Sports in the last year. Their average twelve-month price target is $12.63, suggesting a possible upside of 17.1%. Craig Hallum has the highest price target set, predicting GENI will reach $15.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $11.00 for Genius Sports in the next year.
View the latest price targets for GENI.

What is the current consensus analyst rating for Genius Sports?

Genius Sports currently has 1 hold rating, 14 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GENI will outperform the market and that investors should add to their positions of Genius Sports.
View the latest ratings for GENI.

What other companies compete with Genius Sports?

Other companies that are similar to Genius Sports include Life Time Group, Super Group (SGHC), Madison Square Garden, Rush Street Interactive and Atlanta Braves. Learn More about companies similar to Genius Sports.

How do I contact Genius Sports' investor relations team?

Genius Sports' physical mailing address is 9TH FLOOR 10 BLOOMSBURY WAY, LONDON X0, SW1Y 6DN. The company's listed phone number is 44-20-7851-4060 and its investor relations email address is [email protected]. The official website for Genius Sports is www.geniussports.com. Learn More about contacing Genius Sports investor relations.